AAM Comments on Colorado PDAB Pricing Announcement
Generic and biosimilar medicines save significantly more money for patients and plans than government price controls WASHINGTON (October 7, 2025) — The Association for Accessible Medicines
Generic and biosimilar medicines save significantly more money for patients and plans than government price controls WASHINGTON (October 7, 2025) — The Association for Accessible Medicines
Will cut red tape, bring lower-cost medicines to patients faster WASHINGTON, DC (September 18, 2025) – The Association for Accessible Medicines today thanked the House
AAM analysis shows tactics used by brand drug companies to deny market entry to life-saving lower-cost generic medicines and outlines solutions WASHINGTON, DC (September 4,
90% of all prescriptions filled, yet only 12% of the spending, affordable medicines face severe sustainability challenges in the U.S. WASHINGTON, DC (September 3, 2025)
Brings extensive health insurance and biotech experience WASHINGTON, DC (September 2, 2025) – The Association for Accessible Medicines today welcomes Alex Keeton as the Executive
AAM Congratulates Dr. Tidmarsh on Appointment as Director of CDER WASHINGTON (July 21, 2025) — The Association for Accessible Medicines and the Biosimilars Council today
Expanded capacity adds to current fill and finish products already 100% manufactured in U.S. WASHINGTON, DC (July 15, 2025) – The Association for Accessible Medicines
Matrix Global Advisors analysis shows quantifiable negative impact and a less competitive marketplace with potential lost savings of billions per year WASHINGTON (July 14, 2025)
White paper analyzes problems and solutions to patent abuses WASHINGTON (July 8, 2025) — The Association for Accessible Medicines and its Biosimilars Council today released
39 Groups support the Biosimilar Red Tape Elimination Act WASHINGTON (July 8, 2025) — The Biosimilars Council and the Association for Accessible Medicines today sent
Brings over twenty years of legislative and policy experience WASHINGTON (July 7, 2025) — The Association for Accessible Medicines today welcomes Mark Ratner as Senior
WASHINGTON, DC (June 30, 2025) – The Association for Accessible Medicines today commented on the announcement by Hikma Pharmaceuticals USA to invest $1 billion to
